MSB 1.85% $1.52 mesoblast limited

COVID-19 ARDS and ARDS Share Price Scenarios, page-232

  1. 4,196 Posts.
    lightbulb Created with Sketch. 5493
    Wombat mentions the CHF used only 1% market penetration as per Edison estimates.

    I have no idea why that is the case but they would have had reasons for it.

    It is only treating only 7000 ish patients a year out of 700,000.

    They don't have the cash for it maybe?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.